Melatonin stimulates growth hormone secretion through pathways other than the growth hormone-releasing hormone.

Growth hormone-releasing hormone (GHRH) is another releasing factor secreted by the hypothalamus.

Neuroendocrine neurons, mainly in the ventrolateral part of the nucleus, make growth hormone-releasing hormone (GHRH).

These receptors are distinct from the growth hormone-releasing hormone receptors, and, thus, provide a means of controlling pituitary growth hormone release by the gastrointestinal system.

Inhibit the release of growth hormone thus opposing the effects of growth hormone-releasing hormone (GHRH)

One mechanism for direct effect of PtdIns(4,5)P is opening of Na channels as a minor function in growth hormone release by growth hormone-releasing hormone.

Somatostatin inhibits the actions of Growth Hormone-Releasing Hormone, also a hypothalamus hormone, which controls the release of Growth Hormone.

Still, there are some minor PKA-independent functions of cAMP, e.g., activation of calcium channels, providing a minor pathway by which growth hormone-releasing hormone causes a release of growth hormone.

Endocrine systems controlled by the hypothalamus are regulated by anti-diuretic hormone (ADH), corticotropin-releasing hormone, gonadotropin-releasing hormone, growth hormone-releasing hormone, oxytocin, all of which are secreted by the hypothalamus.

These cells release the peptides Growth hormone-releasing hormone (GHRH or somatocrinin) and Growth hormone-inhibiting hormone (GHIH or somatostatin) into the hypophyseal portal venous blood surrounding the pituitary.

For example, the secretion of growth hormone is controlled by two neuroendocrine systems: the growth hormone-releasing hormone (GHRH) neurons and the somatostatin neurons, which stimulate and inhibit GH secretion, respectively.

The hypothalamus secretes a number of releasing hormones, often according to a circadian rhythm, into hypophyseal portal system; most of these are stimulatory (thyrotropin-releasing hormone, corticotropin-releasing hormone, gonadotropin-releasing hormone and growth hormone-releasing hormone), apart from dopamine, which suppresses prolactin production.

GHRH is released from neurosecretory nerve terminals of these arcuate neurons, and is carried by the hypothalamo-hypophyseal portal system to the anterior pituitary gland where it stimulates growth hormone (GH) secretion by stimulating the growth hormone-releasing hormone receptor.

Tesamorelin (also known as Egrifta) is a synthetic form of growth-hormone-releasing hormone which is used in the treatment of HIV-associated lipodystrophy.

The growth-hormone-releasing hormone (GH-RH) is a member of the VIP family and stimulates Growth Hormone secretion in the anterior pituitary gland.

Growth-hormone-releasing hormone (GHRH), also known as growth-hormone-releasing factor (GRF, GHRF), somatoliberin or somatocrinin, is a releasing hormone for growth hormone.